Search Results - "Marin, Kollef"

Refine Results
  1. 1
  2. 2
  3. 3

    Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study by Zilberberg, Marya D, Shorr, Andrew F, Micek, Scott T, Vazquez-Guillamet, Cristina, Kollef, Marin H

    Published in Critical care (London, England) (21-11-2014)
    “…The impact of in vitro resistance on initially appropriate antibiotic therapy (IAAT) remains unclear. We elucidated the relationship between non-IAAT and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Targeted Fluid Minimization Following Initial Resuscitation in Septic Shock: A Pilot Study by Chen, Catherine, Kollef, Marin H

    Published in Chest (01-12-2015)
    “…IV fluid represents a basic therapeutic intervention for septic shock. Unfortunately, the optimal administration of IV fluid to maximize patient outcomes and…”
    Get full text
    Journal Article
  6. 6

    Nosocomial Infection by Kollef, Marin H., Torres, Antoni, Shorr, Andrew F., Martin-Loeches, Ignacio, Micek, Scott T.

    Published in Critical care medicine (01-02-2021)
    “…The first 70 years of critical care can be considered a period of "industrial revolution-like" advancement in terms of progressing the understanding and care…”
    Get full text
    Journal Article
  7. 7

    Culture-negative sepsis by Thorndike, Jonathan, Kollef, Marin H.

    Published in Current opinion in critical care (01-10-2020)
    “…The traditional approach to sepsis treatment utilizes broad-spectrum antibiotics. Unfortunately, a significant proportion of infected patients have…”
    Get full text
    Journal Article
  8. 8

    Broad-Spectrum Antimicrobials and the Treatment of Serious Bacterial Infections: Getting It Right Up Front by Kollef, Marin H.

    Published in Clinical infectious diseases (15-09-2008)
    “…The treatment of serious bacterial infections is complicated by the fact that time to initiation of effective antimicrobial therapy is a strong predictor of…”
    Get full text
    Journal Article
  9. 9

    Economic Impact of Ventilator-Associated Pneumonia in a Large Matched Cohort by Kollef, Marin H., Hamilton, Cindy W., Ernst, Frank R.

    “…Objective. To evaluate the economic impact of ventilator-associated pneumonia (VAP) on length of stay and hospital costs. Design. Retrospective matched cohort…”
    Get full text
    Journal Article
  10. 10

    A Case-Control Study Assessing the Impact of Nonventilated Hospital-Acquired Pneumonia on Patient Outcomes by Micek, Scott T., PharmD, Chew, Bethany, Hampton, Nicholas, PharmD, Kollef, Marin H., MD

    Published in Chest (01-11-2016)
    “…Background Nonventilated hospital-acquired pneumonia (NVHAP) is a serious nosocomial infection that is increasingly attributed to antibiotic-resistant…”
    Get full text
    Journal Article
  11. 11

    Re-estimating annual deaths due to multidrug-resistant organism infections by Burnham, Jason P, Olsen, Margaret A, Kollef, Marin H

    “…To the Editor—Multidrug-resistant organisms (MDROs) are responsible for an increasing number of infections each year.1 An oft-cited statistic is that MDRO…”
    Get full text
    Journal Article
  12. 12

    Time to Appropriate Antibiotic Therapy Is an Independent Determinant of Postinfection ICU and Hospital Lengths of Stay in Patients With Sepsis by Zhang, David, Micek, Scott T, Kollef, Marin H

    Published in Critical care medicine (01-10-2015)
    “…OBJECTIVE:To assess the timing of appropriate antibiotic therapy as a determinant of postinfection hospital and ICU lengths of stay in patients with sepsis…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Initial antimicrobial management of sepsis by Niederman, Michael S, Baron, Rebecca M, Bouadma, Lila, Calandra, Thierry, Daneman, Nick, DeWaele, Jan, Kollef, Marin H, Lipman, Jeffrey, Nair, Girish B

    Published in Critical care (London, England) (26-08-2021)
    “…Sepsis is a common consequence of infection, associated with a mortality rate > 25%. Although community-acquired sepsis is more common, hospital-acquired…”
    Get full text
    Journal Article
  15. 15

    Is Zero Ventilator-Associated Pneumonia Achievable? Updated Practical Approaches to Ventilator-Associated Pneumonia Prevention by Guillamet, Cristina Vazquez, Kollef, Marin H

    “…Ventilator-associated pneumonia (VAP) remains a significant clinical entity with reported incidence rates of 7% to 15%. Given the considerable adverse…”
    Get full text
    Journal Article
  16. 16

    Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus by Rubinstein, Ethan, Kollef, Marin H., Nathwani, Dilip

    Published in Clinical infectious diseases (01-06-2008)
    “…A recent increase in staphylococcal infections caused by methicillin-resistant Staphylococcus aureus (MRSA), combined with frequent, prolonged ventilatory…”
    Get full text
    Journal Article
  17. 17

    How to use new antibiotics in the therapy of serious multidrug resistant Gram-negative infections? by Windham, Samuel, Kollef, Marin H.

    Published in Current opinion in infectious diseases (01-12-2022)
    “…Multidrug resistant Gram-negative infections are becoming more common and pose a serious threat to both individual patients and the population as a whole…”
    Get full text
    Journal Article
  18. 18

    Sepsis-Associated Coagulopathy Severity Predicts Hospital Mortality by Lyons, Patrick G., Micek, Scott T., Hampton, Nicholas, Kollef, Marin H.

    Published in Critical care medicine (01-05-2018)
    “…OBJECTIVES:To assess whether sepsis-associated coagulopathy predicts hospital mortality. DESIGN:Retrospective cohort study. SETTING:One-thousand three-hundred…”
    Get full text
    Journal Article
  19. 19

    Duration of Exposure to Antipseudomonal β‐Lactam Antibiotics in the Critically Ill and Development of New Resistance by Teshome, Besu F., Vouri, Scott Martin, Hampton, Nicholas, Kollef, Marin H., Micek, Scott T.

    Published in Pharmacotherapy (01-03-2019)
    “…Study Objective Minimizing the duration of broad‐spectrum antimicrobial exposure in the critically ill is a commonly used strategy aimed at preventing…”
    Get full text
    Journal Article
  20. 20